DSIP Sleep Peptide Research: A 9-Amino-Acid Neuropeptide Discovered in Cerebral Blood
DSIP Sleep Peptide Research: A 9-Amino-Acid Neuropeptide Discovered in Cerebral Blood
Delta Sleep-Inducing Peptide (DSIP) is a 9-amino-acid neuropeptide isolated from the cerebral venous blood of sleeping rabbits in 1977. The discovery context — and the half-century of research since — frames how DSIP is studied today: primarily for slow-wave sleep modulation, stress response, and as a molecular probe for understanding sleep architecture.
How DSIP was discovered
Swiss researchers Schoenenberger and Monnier electrically stimulated the thalamus of rabbits to induce sleep, then dialyzed the cerebral venous blood. The dialysate induced slow-wave sleep when transferred to other animals — the active component was DSIP.
The 9-amino-acid sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was characterized over the following decade.
What DSIP does in research
Most-studied effects: increased slow-wave sleep duration, reduced sleep latency in some models, modulation of stress hormone (corticotropin) release, and possible modulation of GABAergic signaling.
DSIP’s exact receptor target remains incompletely characterized — it’s one of the older ‘orphan’ neuropeptides in the literature.
Why it’s still studied 50 years later
DSIP has been a recurring research interest because: (1) sleep architecture remains a hot research area (especially deep sleep and longevity links), (2) DSIP has minimal toxicity in animal models, and (3) the molecular probe value — using DSIP to perturb sleep helps map underlying circuits.
Research has examined DSIP for sleep architecture studies, stress-response models, and as an adjunct in addiction and pain research.
Where DSIP fits in the modern research landscape
Compared to newer sleep-research compounds (orexin antagonists, GABA modulators), DSIP is mechanistically simpler and longer-tenured in the literature. Researchers use it when they want a well-characterized peptide tool rather than a small molecule with broader off-target effects.
Related at LiveWell
Peptide glossary · How to vet peptide sources
Frequently asked questions
What does DSIP stand for?
Delta Sleep-Inducing Peptide. ‘Delta’ refers to delta-wave (slow-wave) sleep, which DSIP was originally identified as inducing.
When was DSIP discovered?
1977, by Swiss researchers Schoenenberger and Monnier. They isolated it from the cerebral venous blood of electrically-stimulated sleeping rabbits.
What receptor does DSIP act on?
DSIP’s exact receptor remains incompletely characterized — it’s one of the older ‘orphan’ neuropeptides in the literature. Multiple mechanisms have been proposed, including effects on GABAergic signaling and corticotropin release.
For laboratory and research use only. LiveWell Peptides products are not intended for human consumption, injection, topical application, or any other administration to the human body. This article is informational and not medical advice.